Form D — TNF Pharmaceuticals, Inc.
0001641172-25-026761 · filed Sep 5, 2025
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $7,000,000
- Total sold
- $7,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- TNF Pharmaceuticals, Inc.
- CIK
- 1321834
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1185 AVENUE OF THE AMERICAS
NEW YORK, NY 10036 - Phone
- 856-848-8698
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ian Rhodes · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Christopher Schreiber · DirectorNew York, NY Find on LinkedIn ↗
-
Joshua Silverman · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Bruce Bernstein · DirectorNew York, NY Find on LinkedIn ↗
-
Bill J. White · DirectorNew York, NY Find on LinkedIn ↗
-
Stephen Friscia · DirectorNew York, NY Find on LinkedIn ↗
-
Mitchell Glass · Executive OfficerNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗